PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Neurol Neurosurg Psychiatry. 1986 July; 49(7): 791–795.
PMCID: PMC1028904

Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome.

Abstract

During the last seven years 65 patients with Gilles de la Tourette's syndrome have been treated. Pimozide was used as the preferred drug because of our experience of treating other hyperkinesias which indicated fewer side-effects than with haloperidol. Of the 65 patients with Gilles de la Tourette's syndrome, 59 were treated with pimozide alone or in combination with tetrabenazine or clonidine. The dose ranges of pimozide were 0.5-9 mg per day. Eighty-one percent experienced a good clinical response without side-effects. The side-effects seen in our patients were sedation, gain in weight, depression, pseudoparkinsonism and akathisia; acute dystonic reactions, blurred vision, slurred speech and xerostomia did not occur. No cases of tardive dyskinesia were seen.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (646K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • SEIGNOT JN. [A case of tic of Gilles de la Tourette cured by R 1625]. Ann Med Psychol (Paris) 1961 Mar;119(1):578–579. [PubMed]
  • Shapiro AK, Shapiro E, Wayne H. Treatment of Tourette's syndrome with haloperidol, review of 34 cases. Arch Gen Psychiatry. 1973 Jan;28(1):92–97. [PubMed]
  • Bruun RD, Shapiro AK, Shapiro E, Sweet R, Wayne H, Solomon GE. A follow-up of 78 patients with Gilles de la Tourette's syndrome. Am J Psychiatry. 1976 Aug;133(8):944–947. [PubMed]
  • Abuzzahab FE, Sr, Anderson FO. Gilles de la Tourette's syndrome; international registry. Minn Med. 1973 Jun;56(6):492–496. [PubMed]
  • Fog R, Pakkenberg H. Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes. Acta Neurol Scand. 1970;46(2):249–251. [PubMed]
  • Fog R, Pakkenberg H. Theoretical and clinical aspects of the Tourette syndrome (chronic multiple tic). J Neural Transm Suppl. 1980;(16):211–215. [PubMed]
  • Pakkenberg H, Fog R. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both. Arch Neurol. 1974 Nov;31(5):352–353. [PubMed]
  • Pakkenberg B, Regeur L, Fog R, Pakkenberg H. Gilles de la Tourette's syndrom. Erfaring med 18 patienter. Ugeskr Laeger. 1982 Oct 18;144(42):3078–3081. [PubMed]
  • Debray P, Messerschmitt P, Lonchamp D, Herbault M. L'utilisation du pimozide en pédo-psychiatrie. Nouv Presse Med. 1972 Dec 2;1(43):2917–2918. [PubMed]
  • Ross MS, Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry. 1978 May;135(5):585–587. [PubMed]
  • Shapiro AK, Shapiro E. Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of tourette syndrome. Adv Neurol. 1982;35:383–386. [PubMed]
  • Shapiro AK, Shapiro E, Eisenkraft GJ. Treatment of Gilles de la Tourette syndrome with pimozide. Am J Psychiatry. 1983 Sep;140(9):1183–1186. [PubMed]
  • Shapiro AK, Shapiro E. An update on Tourette syndrome. Am J Psychother. 1982 Jul;36(3):379–390. [PubMed]
  • Shapiro AK, Shapiro E. Controlled study of pimozide vs. placebo in Tourette's syndrome. J Am Acad Child Psychiatry. 1984 Mar;23(2):161–173. [PubMed]
  • Andén NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 1970;11(3):303–314. [PubMed]
  • Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 1975 Jun 20;188(4194):1217–1219. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group